期刊文献+

ICU多药耐药鲍曼不动杆菌医院感染暴发的危险因素分析 被引量:29

Investigation on an outbreak of multidrug-resistant Acinetobacter baumannii in intensive care unit
下载PDF
导出
摘要 目的调查某院ICU病房下呼吸道多药耐药鲍曼不动杆菌感染暴发的危险因素。方法对ICU病房7例病人2008年1月4~18日发生下呼吸道多药耐药鲍曼不动杆菌院内感染进行流行病学调查分析。结果2008年1月在ICU病房15d内陆续出现7例病人发生下呼吸道多药耐药鲍曼不动杆菌院内感染,其中5例好转,2例死亡。结论流行病学调查表明基础疾病严重、侵入性操作过多,使用抗菌药物,医务人员手及医疗环境污染等是造成此次流行的主要原因。 [Objective] To investigate the risk factor of the patient infected by MDR A. baumanii in ICU, and provide reliable evidence for preventing and monitoring nosocomial infection. [Methods] To study the epidemiology of 7 inpatients who were infected MDR A. baumannii in ICU from January 4 to 18, 2008. [Results] There were 7 inpatients developed lower respiratory tract infection of MDR A. baumannii within 15 days. 5 of the patients recov- ered but 2 died. [Conclusion] The spread of MDR A. baumannii nosocomial infection within the same period was because of using lots of invasive operation toward the patiants, abusing of antibiotic drugs, lack of isolation in the ward and some staff lack of aseptic concept, etc.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第9期1355-1358,共4页 China Journal of Modern Medicine
关键词 ICU 多药耐药鲍曼不动杆菌 医院感染 流行病学调查 ICU muhidrug-resistant acinetobacter baumannii nosocomial infection epidemiologieal investigation
  • 相关文献

参考文献6

二级参考文献31

  • 1张永标,张扣兴,赵锋,杨晓燕,席云,文博,唐英春.鲍曼不动杆菌高活性β-内酰胺酶检测与耐药性变迁[J].中国微生态学杂志,2005,17(6):460-461. 被引量:4
  • 2李家泰,王彤,贾延军,李曼宁.临床分离耐药菌中超广谱β-内酰胺酶特性研究[J].中国临床药理学杂志,1996,12(2):81-84. 被引量:15
  • 3[1]Martino R,Gomez L ,Pericas R et al.Bacteraemia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients withhaemat ologicalmalignancies and solidtumours. Int J Infect Dis,2000; 4(2):85~90
  • 4[2]Lopez-Hernandez S,Alarcon T, Delgado T et al. In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii. Rev Esp-Quimioter,1999;12(2): 140~143
  • 5[5]Rodriguez-Hernandez MJ,Pachon J, Pichardo C,et al. Imipenem,doxycycline and amikacin in monotherapy and in combination in Acinetobacter baum annii experimental pneumonia. J Antimicrob Chemother,2000;45(4):493~501
  • 6[6]Lai SW, Ng KC, Yu WL,et al. Acinetobacter baumannii bloodst reaminfection: clinical features and antimicrobial susceptibilities of isolates.Kao Hsiung I Hsueh Ko Hsueh Tsa Chih,1999;15(7):406~413
  • 7[7]Husni RN, Goldstein LS, Arroliga AC,et al. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosoccmial pneumonia among intu bated patients [see comments] Chest, 1999; 115(5):1378~1382
  • 8Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem[J]. Clin Microbiol Infect, 2002,8(3): 144-153.
  • 9Poirel L,Menuteau O,Agoli N,et al.Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital[J].J Clin Microbiol,2003,41(8):3542-3547.
  • 10Bou G,Martinez-Beltran J.Cloning nucleotide sequencing,and analysis of the geneencoding an AmpC β-lactamase in Acinetobacter baumannii[J].Antimicrob Agents Chemother,2000,44(2):428-432.

共引文献177

同被引文献191

引证文献29

二级引证文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部